Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-11-17

EMA Authorised: Corlentor (ivabradine hydrochloride) — Les Laboratoires Servier

View source ↗

Summary

The EMA authorised Corlentor (ivabradine hydrochloride) for use in angina pectoris and heart failure. Les Laboratoires Servier is the marketing authorization ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corlentor (ivabradine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: Les Laboratoires Servier. Decision date: 13/11/2025